Standard Biotools INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Viking Global Investors has entered into a voting agreement to support Standard BioTools' merger with Treeline Biosciences.
NASDAQ
Casdin Capital has entered into a voting and lock-up agreement to support the proposed merger between Standard BioTools Inc. and Treeline Biosciences, Inc.
NASDAQ
SCHEDULE 13D/A: Casdin Entities Boost Standard BioTools Stake to 24.2%
Casdin Capital and affiliated funds have increased their beneficial ownership in Standard BioTools Inc. to 24.2% through recent open market purchases.
NASDAQ
SCHEDULE 13D/A: Casdin Capital Boosts Stake in Standard BioTools, Signals Strategic Influence Post-SomaLogic Merger
Casdin Capital and its affiliates have increased their beneficial ownership in Standard BioTools Inc. to 20.4%, with Eli Casdin holding 21.6%, following recent share acquisitions and the conversion of preferred stock, reinforcing their strategic investment in the company after its merger with SomaLogic.